Akademisyen profili · ARAŞTIRMA GÖREVLİSİ
REMZİ OKAN AKAR
- Ana Dal Fen Bilimleri ve Matematik Temel Alanı
- Yan Dal Moleküler Biyoloji ve Genetik
- ECZACILIK FAKÜLTESİ
- TEMEL ECZACILIK BİLİMLERİ BÖLÜMÜ
Scopus (SJR)
Q1
6
Q2
3
Q3
3
Q4
1
WoS (JCR)
Q1
3
Q2
4
Q3
3
Q4
3
TR Index
2
makale
Makaleler
- 2026 Enhancing 5-fluorouracil efficacy in colorectal cancer by inhibiting glutathione antioxidant mechanisms with an xCT inhibitor
- 2026 Evaluation of Anticancer Activity of Novel Sulfanyl-Substituted Hydrazone Compounds in Hepatocellular Carcinoma: In Vitro, In Silico, and In Ovo Studies
- 2024 Pd(II) and Pt(II) saccharinate complexes with two phosphine derivatives: Synthesis, anticancer and antiangiogenic activities
- 2024 Biocompatible silver nanoparticles from apricot kernel skin: a green synthesis approach to antibacterial and antiangiogenic therapies
- 2024 Propolis-loaded photocurable methacrylated pullulan films: Evaluation of mechanical, antibacterial, biocompatibility, wound healing and pro-angiogenic abilities
- 2023 Targeting Periostin Expression Makes Pancreatic Cancer Spheroids More Vulnerable to Natural Killer Cells
- 2023 Synthesis, Characterization and Apoptosis Capabilities of a Novel Naphthoquinone-Derived Compound in Triple-Negative Breast Cancer
- 2022 Synthesis, DNA Binding and Cytotoxic Activity of Newcopper(II) Complexes of Trisubstituted Imidazoles
- 2022 Differential Cytotoxic Activity of a New Cationic Pd(II) Coordination Compound with N4-Tetradentate Hybrid Ligand in Cancer Cell Lines
- 2020 A promising therapeutic combination for metastatic prostate cancer: Chloroquine as autophagy inhibitor and palladium(II) barbiturate complex
- 2020 Highly Promising Antitumor Agent of a Novel Platinum(II) Complex Bearing a Tetradentate Chelating Ligand
- 2019 A novel 1,4-naphthoquinone-derived compound induces apoptotic cell death in breast cancer cells
- 2019 Key actors in cancer therapy: epigenetic modifiers
- 2019 The molecular targets of diclofenac differs from ibuprofen to induce apoptosis and epithelial mesenchymal transition due to alternation on oxidative stress management p53 independently in PC3 prostate cancer cells